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Background. Type 1 diabetes mellitus (T1DM) is the most common endocrine disorder in children and adolescents worldwide.
While data about prevalence, treatment, and complications are recorded in many countries, few data exist for Sub-Saharan Africa.
The aim of this study was to determine the degree of control in patients with T1DM aged 1–19 years over a 6-month period in 3
outpatient Kenyan clinics. It also sought to determine how control was influenced by parameters of patient and treatment.Methods.
Eighty-two children and adolescents with T1DMwere included in the study. Clinical history regarding duration of illness, type and
dose of insulin, and recent symptoms of hypoglycemia/hyperglycemiawere recorded. Glycaemia,HbA1c, and ketonuriawere tested.
HbA1c of 8.0% and below was defined as the cut-off for acceptable control. Results.Themedian HbA1c for the study population was
11.1% (range: 6.3–18.8). Overall, only 28% of patients had reasonable glycemic control as defined in this study. 72% therefore had
poor control. It was also found that age above 12 years was significantly associated with poor control. Conclusions. African children
and with T1DM are poorly controlled particularly in adolescents. Our data strongly support the necessity of Kenya children to
receive more aggressive management and follow-up.
1. Introduction
T1DM is the most common endocrine-metabolic disorder
in children and adolescents worldwide, with a prevalence of
190 per 100000 among school aged children in USA and an
annual incidence ranging from 1.7 per 100000 (China) [1] to
40 per 100000 (Finland) [2]. Over the last three decades, the
incidence of T1DMhas been also on the rise worldwide [1–3].
Survey of the published information on T1DM in African
populations reveals that most series do contain several chil-
dren and a significant number of teenagers [4–7]. This shows
that T1DM is not rare in African countries contrary to the
widely held belief.
With the few data available on Sub-Saharan African chil-
dren [4], incidence in Tanzania was estimated to be 1.5/
100,000 [5], and an increase in incidence in Sudan from
9.5/100,000 in 1991 to 10.3/100,000 in 1995 has been shown [6].
Finally, in Africa, a global incidence of 6.4/100.000/year was
reported [7].
Due to limitations in study methods and design, many
of these studies do not provide reliable population data;
however, International Diabetes Federation (IDF) estimates
that there were a total of almost 39,000 prevalent cases of
children with type 1 diabetes in Sub-Saharan Africa in 2013
[7].
The prevalence of type 1 diabetes in Kenyan children and
adolescents is totally unknown. However, approximately 100
patients below the age of 20 years are being followed up
in Nairobi. Despite the apparently small numbers of these
patients, diabetes is amajor health concern because it is a life-
long disease, which uses up substantial financial resources on
both personal and national levels. On the other hand, diabetic
children if well managed can enjoy reasonable well-being and
personal independence [8].
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The main long-term complications of T1DM result from
the effects of prolonged high blood glucose. The Diabetes
Control and Complications Trial (DCCT) showed conclu-
sively that the control of blood glucose has a direct and
significant effect on the development of the triad (nephropa-
thy, retinopathy, and neuropathy) of long-term complications
of T1DM. A reduction of 76% in the risk for development
of retinopathy when average blood glucose and HbA1c are
maintained at 8.6mmol/L and 7.2%, respectively, over a
seven-year period (intensively treated group) was demon-
strated [9]. The DCCT showed that it is indeed possible to
achieve adequate control to make a difference in occurrence
of long-term complications. The patient must be well moti-
vated and the healthcare systemmust be able to give the nec-
essary support in terms of medications and supplies, clinical
care, and advice as required. Although euglycemia was not
achieved even in the DCCT, the improved control resulted in
significant reductions in long-term complications. The con-
trol of blood sugar among Kenyan children and adolescents
with T1DM has not been reliably evaluated. In the absence of
such data, the effectiveness of therapy or any other interven-
tions both currently and in the future cannot be ascertained.
The aim of this study was to determine the degree of
glycemic control in children and adolescents with T1DM and
to try correlating it with the availability of insulin, its type
and dosage, and the role of patient characteristics such as age
and duration of illness. This study also aimed at providing a
baseline on which future work on T1DM in Kenya can build.
2. Methods
The study was carried out at the Kenyatta National Hospital
(KNH) diabetic clinic, the Presbyterian Church of East Africa
(P.C.E.A.)KikuyuHospital, and the diabetes care and training
centre in Nairobi in a period of 6 months and submitted
in partial fulfillment of the requirements for the degree of
Master of Medicine in Pediatrics and Child Health at the
University of Nairobi by the first author (Thomas Ngwiri).
Even if these clinics are not specifically designed for
children and the most part of patients are adults with T2DM,
children with T1DM receive appropriate treatment and edu-
cation; their diabetes is monitored; and where necessary and
possible they are referred to available specialists and support
services. The clinics aim to educate and inform patients and
their relatives to enable them to achieve best possible control
of their condition in a setting with scarce resources. Gen-
erally, any patient is periodically reviewed for blood sugar,
blood pressure, and bodyweightmeasurements. Home blood
sugar monitoring is taught to patients who can afford the
strips. Currently, none of patients can afford regular HbA1c
assays.
All children and adolescents previously diagnosed with
T1DM, beingmanaged with insulin at the 3 facilities and with
at least 2 clinical assessments in this period, were eligible to
participate.
Signed informed consent was obtained from the par-
ent/guardian or subjects below 18 years or from the patient
himself if above 18 years of age. Authority was obtained from
the local ethical committees.
Medical history of the patient in the preceding three
months was taken and recorded on the basis of a structured
anamnestic questionnaire with regard to hyperglycemia and/
or severe hypoglycemia. Considering the fact that only few
patients had glucose monitoring at home, history of polydip-
sia, polyuria, and nocturia was used as clinical evidence of
hyperglycemia. Moreover, on the same basis, history of loss
of consciousness or convulsions, dizziness, unusual sweating,
or tremors requiring help from a third party and corrected
by glucose administration were recorded as severe hypo-
glycemia.
A history of the insulin dosage, availability, and storage in
the last 3 months was also noted. The patient was also being
tested on his/her ability to measure the prescribed dose of
insulin and these findings compared with glycemic control.
In all subjects, a sample of urine was collected and tested
for ketones; moreover, a venous sample of blood was drawn
from a peripheral vein and a fasting blood glucose level and
HbA1c level were measured.
Fasting blood glucose was measured using the
“HemoCue” blood glucose analyzer. HbA1c was determined
only at the second clinical assessment using the HbA1c
Tina Quant II kit (Roche Diagnostics GmbH, Mannheim,
Germany) at the Chemistry Department of the Nairobi
Hospital laboratory.
HbA1c normal range for this assay was 4.8–5.9%.
Urine was collected and tested for ketones using the
“Bayer Diagnostics” ketone test strip.
The questionnaire and blood and urine samples were
given a matching serial number and entered into the study
for analysis. The patient’s level of control and its implications
were explained to the patient/guardian by the attending
clinician at the next clinic visit. Patients were said to have
reasonable control if they had HbA1c of 8% or less and were
said to have poor control if HbA1c was higher than 8%.
The information obtained in this study was discussed
with the patient/primary caregivers and the healthcare
providers to enhance the quality of care to the study subjects.
All data were then analyzed using the Statistical Package
for Social Sciences (SPSS version 11.0) using comparison of
means or chi-square as appropriate. Results are shown as
mean SD.
Odds ratios were also calculated.
3. Results
Theentire population of eligible patients visiting the clinics in
the 6-month period was recruited. A total of 82 patients (39
males and 43 females, age range: 3–19 years, height: −0.31 ±
0.82 SDS, weight: −0.23 ± 0.53 SDS) were studied.This group
represents near half of the registered patients in these clinics
and the total of the patients in regular follow-up.
Thirty-nine of the 82 patients (48%) were residents of
Nairobi, while the remaining 43 (52%) resided in other
districts of Kenya and had to travel to the 3 facilities for
treatment.
The mean age at diagnosis was 9.9 ± 4.4 years and the
median duration of illness was 3.7 years.
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Figure 1: Distribution (%) of HbA1c in children and adolescents.
Of the patients identified for the study after meeting the
inclusion criteria nobody was excluded from analysis.
Although 90% of the patients were recruited at KNH,
it was noted that patients had moved freely among the 3
facilities in the 6 months preceding the study so no attempt
was made to analyze control separately for each institution.
The male to female ratio of the study population
approached one.
Values of HbA1c were not normally distributed: their
range was 6.4–19%, median HbA1c was 12.1%, and interquar-
tile range was 7.20. The overall prevalence of poor control
was 72% when a cut-off HbA1c of 8% was used (Figure 1).
Children in the group with lowest levels of HbA1c were in
honeymoon period.
The percentage of children experiencing severe hypo-
glycemia (53.6%) was lower than the percentage of children
with hyperglycemia (86%).
Only about one-third of patients in the study had fridges
to store their insulin. Control in this group was not sig-
nificantly better than in those who kept their insulin at
room temperature. Those patients using “pots” (improvised
refrigerator) also appeared to have similar control to those
who stored their insulin at room temperature.
The dose of insulin is highly individualized as it is titrated
against the patients control during the course of follow-up.
All children received a conventional insulin regimen (mean
dose: 0.9 ± 0.4UI/kg/day; range: 0.5–1.7UI/kg/day).
In this study, control was compared between those whose
insulin dose was at least 0.6UI/kg and those whose dose fell
below this cut-off. Control was similar in the 2 groups.
Fifty-eight of the 82 patients, 69% of patients, used only
mixed formulation insulin, while the rest used intermediate
acting insulin alone or together with a short acting variety
in a home-prepared mixture. In all these patients, this was
necessitated by unavailability of mixed formulation and not
by preference for an alternative formulation.
Eleven% of patients admitted that they took refined
sugars between daily basis and weekly basis as compared to
the majority who took them not more than once a month.
Control was better in those children who restricted their
refined sugar intake, although the difference was not signifi-
cant.
In this study, only 4%of children>12 years had reasonable
control compared to 78% in children <12 years of age.
Statistical analysis demonstrates that patients’ age was a
determinant of glycemic control (𝑃 < 0.0001) as confirmed
by odds ratio value.
No statistically significant differences were shown for sex,
residence, primary care givers, family history of diabetesmel-
litus, insulin formulation, use of refined sugar, and duration
of illness in determining the degree of metabolic control
(Tables 1 and 2).
4. Discussion
Only 28% of Kenyan children and adolescents with T1DM
had reasonable control. This result is partially in agreement
with the few studies in African children showing the mean
HbA1c above 10.5% [10–13] with a study having the mean
HbA1c as high as 12.5% [14]. Our data compare to those of
a study from Ethiopia where reasonable control was found
in 22% of patients [13] and are better than those obtained in
Sudan where reasonable control was found in only 12.5% of
patients [10, 11].
As would be expected, control was poorer than that in
most patients studied by Hvidøre Study Group [15], with
a more prosperous economy and therefore better access to
healthcare.
Most likely, the underlying cause is the association
between limited insulin supply and near total lack of self-
monitoring of blood glucose due to the limited availability
of economic resources. The same scarcity of resources blocks
the possibility of routinely assessing the level of HbA1c.
Therefore, the costs of diabetes result in a formidable barrier
to improve the control of this noncommunicable disease. In
African countries, the global direct cost of care approaches
300$ corresponding to the annual income of many families.
In the absence of a publically funded healthcare system, these
costs are borne almost entirely by individuals. In this context,
poor disease prognosis with high morbidity and mortality
seem to be the unavoidable outcomes [16].
In our population, we showed a high prevalence of both
severe hypoglycemia and hyperglycemia.However, these data
have to be considered cautiously because they are based on
symptoms and not always on glucose measurements. Hyper-
glycemia, moreover, can be reflecting the shortage of insulin.
This can concur with the high recurrence of ketoacidosis
in African children with T1DM [17]. Females had slightly
poorer glycemic control than their male counterparts as
previously shown in other pubertal African girls [14]. Similar
findings were observed also in Japan, where the average
HbA1c in females remained significantly higher than inmales
over more than 5 years of follow-up [18]. Adolescent girls
experience a significant deterioration in control towards the
end of growth [19].
In our study, to live in rural setting does not influence the
metabolic control.Thus, the controlwas similar in all children
independently by residing in or out of Nairobi, probably
reflecting the relative importance of treatment practice over
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Table 1: Sociodemographic factors and glycemic control.
Factor HbA1c < 8.0% HbA1c ≥ 8.0 𝜒2 𝑃 value Odds ratio (95% CI)
Sex
Male 12 (33%) 26 (66%) 0.44 0.623 1.18 (0.53–3.64)
Female 11 (25%) 33 (75%)
Residence
Nairobi 13 (33%) 26 (66%) 1.03 0.310 1.65 (0.62–4.36)
Others 10 (23%) 33 (77%)
Primary caregiver
Parent 20 (30%) 46 (70%) 0.85 0.356 1.88 (0.48–7.35)
Other 3 (19%) 13 (81%)
Family history of DM
Yes 9 (27%) 24 (73%) 0.02 0.897 0.94 (0.35–2.51)
No 14 (29%) 35 (71%)
Insulin formulation
Intermediate acting 4 (25%) 12 (75%) 0.195 0.6588 0.75 (0.22–2.64)
Mixed 19 (33%) 43 (67%)
Use of refined sugar
Frequent 1 (11%) 8 (89%) 0.6 0.431 0.30 (0.04–2.53)
Rare 21 (30%) 50 (70%)
Age (current)
<12 years 21 (78%) 6 (22%) 45.73 <0.0001 92.7 (17.3–496.8)
≥12 years 2 (4%) 53 (96%)
Age at diagnosis
<12 years 6 (22%) 21 (78%) 0.32 0.448 0.64 (0.22–1.87)
≥12 years 17 (31%) 38 (69%)
Duration of illness
<5 years 19 (31%) 41 (69%) 1.451 0.2285 2.09 (0.62–7.01)
≥5 years 4 (19%) 18 (81%)
Table 2: Insulin handling and glycemic control.
Factor
𝑁
Mean HbA1c (standard deviation) Standard error (SE) 𝑃 value
Place of storage
Fridge 28 10.189 (4.1176) 0.7781 0.234
Room temp. 9 12.400 (4.1158) 1.3719
Place of storage
Pot 40 11.433 (4.2589) 0.6734 0.539
Room temp. 9 12.400 (4.1158) 1.3719
Insulin dose
≥0.6U/kg/day 54 11.041 (4.1120) 0.5596 0.991
<0.6U/kg/day 28 11.053 (4.2166) 0.9673
Dosing regimen
Twice daily 76 11.030 (4.2464) 0.4936 0.258
Thrice daily 4 12.850 (2.5749) 1.2874
Accurate measurement of insulin
Yes 77 10.997 (4.2102) 0.4862 0.573
No 5 13.200 (2.5755) 1.2878
Missed insulin (unavailability)
Yes 12 12.756 (4.7101) 1.5700 0.216
No 70 10.910 (4.1020) 0.4938
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the physical environment and diverse diets in the successful
management of type 1 diabetes.The landmark DCCT [9] had
shown that good control was achievable anywhere with
aggressive management.
The majority of patients had a parent as the primary care
giver. These children did not fare better with their control
than those under care of siblings and other relatives. Parents
are probablymore committed to their children with a chronic
illness and ensure better compliance with medication. Chil-
dren under care of their parents alsomight enjoy a stable fam-
ily structure that is more supportive. It has been shown that
there was a direct association between parental involvement
in insulin administration and metabolic control in diabetic
adolescents, although no such association was found with
the “wider family functioning” using the Family Assessment
Device [20]. Another study [21] also established that control
was indeed better in those children whom both parents lived
at home. However, the relationship between family function-
ing (namely, atmealtimes) and children’s health outcomes has
to be yet fully elucidated [22].
The lack of a difference in our study might be explained
by the fact that many Kenyan homes comprise an extended
family whose members assume responsibility for the care of
a sick sibling or other relative just like a parent would.
Families with experience in the care of another diabetic
might be expected to be better suited for the care of a diabetic
child by providing appropriate diet and correct and con-
sistent administration of medication and generally offering
psychosocial support. The author is not aware of studies that
have specifically addressed the quality of care of children
with family history of diabetes. In our study population, the
control was similar in those with or without diabetic relatives.
The DCCT study [9] had established that control
improved withmultiple dose injections or continuous subcu-
taneous infusion of insulin. These recommendations caused
a high proportion of children and adolescents with T1DM
in developed countries to receive intensive treatment. A
crossover study from conventional to flexible multiple daily
insulin showed an improvement in both preadolescent con-
trol and pubertal children’s control [23]. This requires a
highly motivated patient who must practice home glucose
monitoring several times a day. The economic problems of
African countries put an obstacle in the way of intensive
treatment. Wide use of mixed formulations recorded in our
patients is the standard practice in Africa. As reported by
Majaliwa et al. [14], it is unlikely that self-monitoring of blood
glucose can be economically sustained by patients living in
these countries. It is to underline, however, that all 8 patients
with a limited access to self-monitoring are among those with
a good metabolic control. Pawar et al. [24], on the other
hand, found that the benefits of multiple dose regimens seen
in research settings were not always reproducible in routine
clinics. They found control was poorer in patients on four as
compared to two daily injections in a routine clinic in theUK.
In our study, the number of patients on thrice daily injections
was extremely small (5% of study subjects). They also had
been put on thrice daily injections only after failing to be
controlled on twice daily regimen and so were likely to be
patients with poor control in the first place.
While in other African countries the storage of insulin
can play role in the overall metabolic control [14], this does
not happen in our environment where temperatures remain
around 25 degrees centigrade. Refrigeration where available
should still remain the storage of choice especially in hotter
parts of the country where temperatures frequently exceed
25 degrees centigrade. Insulin can still be safely kept at room
temperature as long as it is used within one calendar month
and the ambient temperature remains below 25 degrees
centigrade, a situation that is difficult to guarantee in the
tropics. There is no data on the temperatures achieved in
“pots.”This should be ascertained and if acceptable the use of
“pots” should be promoted more authoritatively as an alter-
native for patients without access to a refrigerator.
In Kenya and specifically at KNH which has a high
turnover of patients on insulin and which must provide the
drug at a highly subsidized price (15% of the price at private
pharmacy outlets), insulin shortages are not uncommon.The
extent and impact of shortages on the glycemic control in
Kenya have not been evaluated.
Our study was not designed to verify the report of the
patient’s compliance and relied on recall. However, only 10 out
of 82 patients reported that they had missed their prescribed
dose of insulin because they lacked the drug. Those who did
so had poorer control than those who reported that they had
been compliant throughout the preceding 3 months. While
these results are in keeping with the scientific fact that insulin
is all-important in control of blood sugar, it is still significant
that even those who reported good compliance still had a
very poor control. Therefore, we can have some doubts on
the real compliance of these patients. On the other hand, our
study does not address the difference between the prescribed
dose and dispensed dose of insulin and so cannot verify
compliance with the prescribed dose.
Elbagir et al. [10] in Sudan had found that patients faced
with scarcity of insulin actually reduced their insulin per dose
or the number of doses per day in order to stretch their supply.
Tanzanian children with T1DM, in addition to limited
supply, reduce spontaneously the prescribed dose of insulin
to guaranty a longer period and lower cost of treatment [14].
It is not clear from our study if the same happens in Kenya.
In our patients, age was an important determinant of
metabolic control. In agreement, a nationwide study of more
than 2500 French children [23] showed age as the most
important factor related to control followed by insulin dosage
and maternal age. Pawar et al. [24] had similar findings and
concluded that mean HbA1c rose with age from 10 years of
age over a 6-year follow-up. In the DIABAUD2 study [21],
HbA1c was significantly lower in children below 10 years as
compared to those between 10 and 15 years. Children diag-
nosed with diabetes before 12 years of age had slightly poorer
control than those diagnosed later and in adolescents the con-
trol was unacceptably impaired [25]. Gebre-Yohannes and
Rahlenbeck [13] had also found that lower age of onset was
a predictor of poor control in Ethiopian children with T1DM.
Control was also inversely related to duration of illness.
However, the correlation reported in our and other studies
betweenHbA1C and agewas not found inTanzanian children
with T1DM [14].
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However, it has been shown that there was a delay in the
onset of complications of diabetes in thosewith a longer dura-
tion of prepubertal diabetes as compared with the duration of
postpubertal disease [23].This finding hasmajor implications
in setting target HbA1c levels for young children who are
prone to hypoglycemia.
Our study demonstrated that the prevalence of poor
diabetic control in Kenyan children and adolescents is far
from being acceptable and the great majority of patients are
at high risk for the precocious development of microvas-
cular complications. Moreover, it must be highlighted that
severe hypoglycemia is often recorded in African setting
and it can complicate the control. As worldwide, Kenyan
adolescents with T1DM have particularly poor control so
they comprise a special high-risk group in the diabetes clinic.
Our data strongly have supported the necessity of children
and adolescents with T1DM in Kenya receiving more aggres-
sive management and follow-up and more resources are
addressed at the care of this noncommunicable disease.
Just to overcome some structural barriers in coping with
diabetes in the African setting [26], in the last years, the
assistance to the children with T1DM has improved offering
many free bloodmeters and blood strips and near-free access
of insulin, with the help of the Pediatric Endocrinology
TrainingCenter, sponsored by the European Society Pediatric
Endocrinology and the World Diabetes Foundation.
Moreover, a more strict collaboration has been promoted
between adult and pediatric diabetologists and a valuable
assistance from the diabetic education unit with nurse and
educator has been obtained.
Further studies should be carried out to determine the
impact of these increased resources and this new attitude on
the metabolic control, especially in adolescent patients.
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